After being diagnosed with stage 3C breast cancer, retired teacher Janet Fuller sought a treatment approach that aligned with ...

Dr. Jeremy Hollis talks with John Higgins about the two molecular mysteries that he solved on the way to earning his ...

T-cell acute lymphoblastic leukemia (ALL) is a less common subtype of acute lymphoblastic leukemia. It happens more often in adults than in children. T-cell ALL starts in immature cells that would ...

Graced with good weather and even better science, the 2026 International Invasive Lobular Carcinoma (ILC) Symposium, held ...

Despite a tumultuous year of changes and proposed changes to the way the federal government invests in scientific research, the director of the National Cancer Institute, Anthony Letai, MD, PhD, sees ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

This event is open only to students and alumni of the University of Virginia. The Virtual Fall Job & Internship Fair connects students and employers across the biotech, science, healthcare, and life ...

The Biostatistics Program at Fred Hutch Cancer Center is recognized as one of the leading centers for biostatistical research and collaboration in the United States. Our faculty develop and apply ...

IN for the Hutch is Innovators Network's (IN) annual celebration of science, where next-generation doers come together to ignite big ideas with the potential to end cancer and related diseases in our ...

Fred Hutch scientists conduct research on and develop therapies for many cancers — including blood cancers and solid tumors — as well as for HIV and other nonmalignant diseases. Our scientists study ...

The humble lab mouse is the workhorse for immunology research, especially antibody discovery. Immunizing mice with pathogens or recombinant antigens triggers an antibody response by mouse B cells, ...